| pubmed-article:10856107 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10856107 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:10856107 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:10856107 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:10856107 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:10856107 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:10856107 | pubmed:dateCreated | 2000-7-18 | lld:pubmed |
| pubmed-article:10856107 | pubmed:abstractText | To investigate dose escalation of oral paclitaxel in combination with dose increment and scheduling of cyclosporine (CsA) to improve the systemic exposure to paclitaxel and to explore the maximum-tolerated dose (MTD) and dose-limiting toxicity (DLT). | lld:pubmed |
| pubmed-article:10856107 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10856107 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10856107 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10856107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10856107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10856107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10856107 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10856107 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10856107 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10856107 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:BeijnenJ HJH | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:RosingHH | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:SchellensJ... | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:SwartMM | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:KoopmanF JFJ | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:DuchinKK | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:TerwogtJ MJM | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:HuininkW WWW | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:LieverstJJ | lld:pubmed |
| pubmed-article:10856107 | pubmed:author | pubmed-author:MalingréM MMM | lld:pubmed |
| pubmed-article:10856107 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10856107 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:10856107 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10856107 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10856107 | pubmed:pagination | 2468-75 | lld:pubmed |
| pubmed-article:10856107 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:meshHeading | pubmed-meshheading:10856107... | lld:pubmed |
| pubmed-article:10856107 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10856107 | pubmed:articleTitle | Phase I and pharmacokinetic study of oral paclitaxel. | lld:pubmed |
| pubmed-article:10856107 | pubmed:affiliation | Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Utrecht, The Netherlands. apmmg@slz.nl | lld:pubmed |
| pubmed-article:10856107 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10856107 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10856107 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10856107 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10856107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10856107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10856107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10856107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10856107 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10856107 | lld:pubmed |
